Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6068602 | The Journal of Allergy and Clinical Immunology: In Practice | 2014 | 11 Pages |
Abstract
Based on the level of treatment, 8.1% of a nationwide population of current patients with asthma was classified as having severe asthma. Low asthma control was more frequent among subjects with severe asthma, and only a minority had access to specialist care. There is room for optimizing asthma management, particularly among patients with severe disease.
Keywords
ACElong-acting anticholinergicICD-10ICSSABAATCLTRALAMAAsthmaSevere asthmaAngiotensin-converting-enzymeLong-acting β2-agonistShort-acting β2-agonistemergency departmentChronic obstructive pulmonary diseaseCOPDLABAAnatomical Therapeutic Chemical ClassificationAsthma managementCrude odds ratioGeneral practitionerAsthma controlInhaled corticosteroid
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Anna MD, Margit MSc, PhD, Vibeke MD, DMSc, Celeste MD, PhD,